日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis

VALOR-CKD:一项多中心、随机、双盲、安慰剂对照试验,评估维维瑞默在延缓代谢性酸中毒患者慢性肾脏病进展中的疗效。

Tangri, Navdeep; Mathur, Vandana S; Bushinsky, David A; Klaerner, Gerrit; Li, Elizabeth; Parsell, Dawn; Stasiv, Yuri; Walker, Michael; Wesson, Donald E; Wheeler, David C; Perkovic, Vlado; Inker, Lesley A

Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD

一项随机对照试验研究了TRC101提高慢性肾脏病患者血清碳酸氢盐水平的疗效。

Bushinsky, David A; Hostetter, Thomas; Klaerner, Gerrit; Stasiv, Yuri; Lockey, Claire; McNulty, Sarah; Lee, Angela; Parsell, Dawn; Mathur, Vandana; Li, Elizabeth; Buysse, Jerry; Alpern, Robert

Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia

帕替罗默可使慢性肾脏病合并高钾血症患者的血钾水平迅速且持续降低。

Bushinsky, David A; Williams, Gordon H; Pitt, Bertram; Weir, Matthew R; Freeman, Mason W; Garza, Dahlia; Stasiv, Yuri; Li, Elizabeth; Berman, Lance; Bakris, George L

Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors

帕替罗默对降低血清钾水平及预防接受 RAAS 抑制剂治疗的心力衰竭合并慢性肾病患者复发性高钾血症的影响

Pitt, Bertram; Bakris, George L; Bushinsky, David A; Garza, Dahlia; Mayo, Martha R; Stasiv, Yuri; Christ-Schmidt, Heidi; Berman, Lance; Weir, Matthew R

noxin, a novel stress-induced gene involved in cell cycle and apoptosis.

noxin,一种新型的应激诱导基因,参与细胞周期和细胞凋亡

Nakaya Naoki, Hemish Jill, Krasnov Peter, Kim Sang-Yong, Stasiv Yuri, Michurina Tatyana, Herman Daniel, Davidoff Michail S, Middendorff Ralf, Enikolopov Grigori